Updated version of the Argireline peptide. Marketing promises a reduction of expression wrinkles «like botox», but clinical effects are much more modest.
Topical application
DVery weak or conflicting data.
The peptide is too large for effective penetration through the stratum corneum. Manufacturer studies show slight relief smoothing; independent RCTs reproduce the result poorly.
Irritation potential
LowAllergen risk
LowPregnancy
UnknownSuitable for
Safety data for Acetyl Hexapeptide-37 during pregnancy is insufficient. Best avoided when in doubt.
Acetyl Hexapeptide-37 suits: oily, dry, combination, normal.
Updated version of the Argireline peptide.
The INCI name is Acetyl Hexapeptide-37. It may also appear as: Argireline XL.
Published: · updated: